[Dronedarone].
Published in Herzschrittmachertherapie & Elektrophysiologie • Dec 1, 2010
Authors:
B-D Gonska
Abstract
Dronedarone is a new antiarrhythmic agent, approved in January 2010 for the therapy of atrial fibrillation and for rate control in tachyarrhythmic atrial fibrillation. It was developed with the goal of replicating the high antiarrhythmic potency of amiodarone but with fewer side effects. An essentia...
Finding related papers...
Discussions
(0)No comments yet
Be the first to share your thoughts!